Laurent Meijer - Publications

Publications (51)

ECB-PERS-4190

Publications By Laurent Meijer

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Butyrolactone I derivatives from Aspergillus terreus carrying an unusual sulfate moiety., Niu X, Dahse HM, Menzel KD, Lozach O, Walther G, Meijer L, Grabley S, Sattler I., J Nat Prod. April 1, 2008; 71 (4): 689-92.
7-Bromoindirubin-3''-oxime induces caspase-independent cell death., Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofé-Ochoa X, Totzke F, Schächtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J, Meijer L., Oncogene. October 12, 2006; 25 (47): 6304-18.
Synthesis of novel 5-substituted indirubins as protein kinases inhibitors., Beauchard A, Ferandin Y, Frère S, Lozach O, Blairvacq M, Meijer L, Thiéry V, Besson T., Bioorg Med Chem. September 15, 2006; 14 (18): 6434-43.
Screening the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2 kinase., Yang H, Zheng S, Meijer L, Li SM, Leclerc S, Yu LL, Cheng JQ, Zhang SZ., J Zhejiang Univ Sci B. July 1, 2005; 6 (7): 656-63.
CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents., Pies T, Schaper KJ, Leost M, Zaharevitz DW, Gussio R, Meijer L, Kunicke C., Arch Pharm (Weinheim). September 1, 2004; 337 (9): 486-92.
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials., Meijer L, Raymond E., Acc Chem Res. June 1, 2003; 36 (6): 417-25.
Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein., Vogel L, Baratte B, Détivaud L, Azzi L, Leopold P, Meijer L., Biochim Biophys Acta. April 3, 2002; 1589 (2): 219-31.
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum., Harmse L, van Zyl R, Gray N, Schultz P, Leclerc S, Meijer L, Doerig C, Havlik I., Biochem Pharmacol. August 1, 2001; 62 (3): 341-8.
Purification of GSK-3 by affinity chromatography on immobilized axin., Primot A, Baratte B, Gompel M, Borgne A, Liabeuf S, Romette JL, Jho EH, Costantini F, Meijer L., Protein Expr Purif. December 1, 2000; 20 (3): 394-404.
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors., Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF, Le Roch K, Doerig C, Schultz P, Meijer L., Chem Biol. June 1, 2000; 7 (6): 411-22.
2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity., Kunick C, Schultz C, Lemcke T, Zaharevitz DW, Gussio R, Jalluri RK, Sausville EA, Leost M, Meijer L., Bioorg Med Chem Lett. March 20, 2000; 10 (6): 567-9.
Characterization of a novel cdk1-related kinase., Détivaud L, Pettit GR, Meijer L., Eur J Biochem. August 1, 1999; 264 (1): 55-66.
Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity., Schultz C, Link A, Leost M, Zaharevitz DW, Gussio R, Sausville EA, Meijer L, Kunick C., J Med Chem. July 29, 1999; 42 (15): 2909-19.
Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors., Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V., Bioorg Med Chem. July 1, 1999; 7 (7): 1281-93.
Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition., Borgne A, Ostvold AC, Flament S, Meijer L., J Biol Chem. April 23, 1999; 274 (17): 11977-86.
Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases., Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L., Bioorg Med Chem Lett. April 7, 1998; 8 (7): 793-8.
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds., Havlícek L, Hanus J, Veselý J, Leclerc S, Meijer L, Shaw G, Strnad M., J Med Chem. February 14, 1997; 40 (4): 408-12.
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine., De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH., Eur J Biochem. January 15, 1997; 243 (1-2): 518-26.
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5., Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP., Eur J Biochem. January 15, 1997; 243 (1-2): 527-36.
Chemical inhibitors of cyclin-dependent kinases., Meijer L, Kim SH., Methods Enzymol. January 1, 1997; 283 113-28.
Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition., Borgne A, Meijer L., J Biol Chem. November 1, 1996; 271 (44): 27847-54.
Purification of a 15-kDa cdk4- and cdk5-binding protein., Azzi L, Meijer L, Ostvold AC, Lew J, Wang JH., J Biol Chem. May 6, 1994; 269 (18): 13279-88.
8-Dimethylamino-1-methyladenine, a novel potent antagonist of the 1-methyladenine receptor in starfish oocytes., Monsees T, Meijer L, Jastorff B., Eur J Biochem. April 1, 1993; 213 (1): 155-65.
Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2., Azzi L, Meijer L, Reed SI, Pidikiti R, Tung HY., Eur J Biochem. February 1, 1992; 203 (3): 353-60.
Allene oxide and aldehyde biosynthesis in starfish oocytes., Brash AR, Hughes MA, Hawkins DJ, Boeglin WE, Song WC, Meijer L., J Biol Chem. December 5, 1991; 266 (34): 22926-31.
Cyclin B targets p34cdc2 for tyrosine phosphorylation., Meijer L, Azzi L, Wang JY., EMBO J. June 1, 1991; 10 (6): 1545-54.
High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase., Meijer L, Ostvold AC, Walass SI, Lund T, Laland SG., Eur J Biochem. March 28, 1991; 196 (3): 557-67.
A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates., Rialet V, Meijer L., Anticancer Res. January 1, 1991; 11 (4): 1581-90.
Negative control of cdc2 kinase activation by cAMP in starfish oocytes., Meijer L, Arion D., Cold Spring Harb Symp Quant Biol. January 1, 1991; 56 591-8.
Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components., Pondaven P, Meijer L, Beach D., Genes Dev. January 1, 1990; 4 (1): 9-17.
M-phase-specific protein kinase from mitotic sea urchin eggs: cyclic activation depends on protein synthesis and phosphorylation but does not require DNA or RNA synthesis., Arion D, Meijer L., Exp Cell Res. August 1, 1989; 183 (2): 361-75.
Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase., Meijer L, Arion D, Golsteyn R, Pines J, Brizuela L, Hunt T, Beach D., EMBO J. August 1, 1989; 8 (8): 2275-82.
Starfish oocyte maturation: evidence for a cyclic AMP-dependent inhibitory pathway., Meijer L, Dostmann W, Genieser HG, Butt E, Jastorff B., Dev Biol. May 1, 1989; 133 (1): 58-66.
Activation of myelin basic protein kinases during echinoderm oocyte maturation and egg fertilization., Pelech SL, Tombes RM, Meijer L, Krebs EG., Dev Biol. November 1, 1988; 130 (1): 28-36.
cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF., Arion D, Meijer L, Brizuela L, Beach D., Cell. October 21, 1988; 55 (2): 371-8.
Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions., Meijer L, Pondaven P., Exp Cell Res. January 1, 1988; 174 (1): 116-29.
Characterization of maturation-activated histone H1 and ribosomal S6 kinases in sea star oocytes., Pelech SL, Meijer L, Krebs EG., Biochemistry. December 1, 1987; 26 (24): 7960-8.
Differential regulation of histone H1 and ribosomal S6 kinases during sea star oocyte maturation., Meijer L, Pelech SL, Krebs EG., Biochemistry. December 1, 1987; 26 (24): 7968-74.
Starfish oocyte maturation: 1-methyladenine triggers a drop of cAMP concentration related to the hormone-dependent period., Meijer L, Zarutskie P., Dev Biol. June 1, 1987; 121 (2): 306-15.
Stereospecific induction of starfish oocyte maturation by (8R)-hydroxyeicosatetraenoic acid., Meijer L, Brash AR, Bryant RW, Ng K, Maclouf J, Sprecher H., J Biol Chem. December 25, 1986; 261 (36): 17040-7.
Contrasting effects of fatty acids on oocyte maturation in several starfish species., Meijer L, Maclouf J, Bryant RW., Prostaglandins Leukot Med. August 1, 1986; 23 (2-3): 179-84.
Protein phosphorylation and oocyte maturation. I. Induction of starfish oocyte maturation by intracellular microinjection of a phosphatase inhibitor, alpha-naphthylphosphate., Pondaven P, Meijer L., Exp Cell Res. April 1, 1986; 163 (2): 477-88.
Protein phosphorylation and oocyte maturation. II. Inhibition of starfish oocyte maturation by intracellular microinjection of protein phosphatases 1 and 2A and alkaline phosphatase., Meijer L, Pondaven P, Tung HY, Cohen P, Wallace RW., Exp Cell Res. April 1, 1986; 163 (2): 489-99.
Arachidonic acid, 12- and 15-hydroxyeicosatetraenoic acids, eicosapentaenoic acid, and phospholipase A2 induce starfish oocyte maturation., Meijer L, Guerrier P, Maclouf J., Dev Biol. December 1, 1984; 106 (2): 368-78.
Maturation and fertilization in starfish oocytes., Meijer L, Guerrier P., Int Rev Cytol. January 1, 1984; 86 129-96.
Calmodulin in starfish oocytes. II. Trypsin treatment suppresses the trifluoperazine-sensitive step., Meijer L, Guerrier P., Dev Biol. January 1, 1984; 101 (1): 257-62.
Immobilized methylglyoxal-bis(guanylhydrazone) induces starfish oocyte maturation., Meijer L, Guerrier P., Dev Biol. December 1, 1983; 100 (2): 308-17.
Trifluoperazine-Sensitive Step during Sea Urchin, Echiuroid and Pelecypod Egg Activation: (trifluoperazine/calmodulin/calcium/maturation/fertilization)., Meijer L, Dube F, Guerrier P., Dev Growth Differ. January 1, 1983; 25 (5): 469-475.
Activation of calmodulin-dependent NAD+ kinase by trypsin., Meijer L, Guerrier P., Biochim Biophys Acta. March 18, 1982; 702 (1): 143-6.
The role of calcium in meiosis reinitiation., Guerrier P, Moreau M, Meijer L, Mazzei G, Vilain JP, Dubé F., Prog Clin Biol Res. January 1, 1982; 91 139-55.

Butyrolactone I derivatives from Aspergillus terreus carrying an unusual sulfate moiety., Niu X, Dahse HM, Menzel KD, Lozach O, Walther G, Meijer L, Grabley S, Sattler I., J Nat Prod. April 1, 2008; 71 (4): 689-92.

7-Bromoindirubin-3''-oxime induces caspase-independent cell death., Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofé-Ochoa X, Totzke F, Schächtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J, Meijer L., Oncogene. October 12, 2006; 25 (47): 6304-18.

Synthesis of novel 5-substituted indirubins as protein kinases inhibitors., Beauchard A, Ferandin Y, Frère S, Lozach O, Blairvacq M, Meijer L, Thiéry V, Besson T., Bioorg Med Chem. September 15, 2006; 14 (18): 6434-43.

Screening the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2 kinase., Yang H, Zheng S, Meijer L, Li SM, Leclerc S, Yu LL, Cheng JQ, Zhang SZ., J Zhejiang Univ Sci B. July 1, 2005; 6 (7): 656-63.

CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents., Pies T, Schaper KJ, Leost M, Zaharevitz DW, Gussio R, Meijer L, Kunicke C., Arch Pharm (Weinheim). September 1, 2004; 337 (9): 486-92.

Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials., Meijer L, Raymond E., Acc Chem Res. June 1, 2003; 36 (6): 417-25.

Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein., Vogel L, Baratte B, Détivaud L, Azzi L, Leopold P, Meijer L., Biochim Biophys Acta. April 3, 2002; 1589 (2): 219-31.

Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum., Harmse L, van Zyl R, Gray N, Schultz P, Leclerc S, Meijer L, Doerig C, Havlik I., Biochem Pharmacol. August 1, 2001; 62 (3): 341-8.

Purification of GSK-3 by affinity chromatography on immobilized axin., Primot A, Baratte B, Gompel M, Borgne A, Liabeuf S, Romette JL, Jho EH, Costantini F, Meijer L., Protein Expr Purif. December 1, 2000; 20 (3): 394-404.

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors., Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF, Le Roch K, Doerig C, Schultz P, Meijer L., Chem Biol. June 1, 2000; 7 (6): 411-22.

2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity., Kunick C, Schultz C, Lemcke T, Zaharevitz DW, Gussio R, Jalluri RK, Sausville EA, Leost M, Meijer L., Bioorg Med Chem Lett. March 20, 2000; 10 (6): 567-9.

Characterization of a novel cdk1-related kinase., Détivaud L, Pettit GR, Meijer L., Eur J Biochem. August 1, 1999; 264 (1): 55-66.

Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity., Schultz C, Link A, Leost M, Zaharevitz DW, Gussio R, Sausville EA, Meijer L, Kunick C., J Med Chem. July 29, 1999; 42 (15): 2909-19.

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors., Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V., Bioorg Med Chem. July 1, 1999; 7 (7): 1281-93.

Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition., Borgne A, Ostvold AC, Flament S, Meijer L., J Biol Chem. April 23, 1999; 274 (17): 11977-86.

Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases., Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L., Bioorg Med Chem Lett. April 7, 1998; 8 (7): 793-8.

Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds., Havlícek L, Hanus J, Veselý J, Leclerc S, Meijer L, Shaw G, Strnad M., J Med Chem. February 14, 1997; 40 (4): 408-12.

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine., De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH., Eur J Biochem. January 15, 1997; 243 (1-2): 518-26.

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5., Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP., Eur J Biochem. January 15, 1997; 243 (1-2): 527-36.

Chemical inhibitors of cyclin-dependent kinases., Meijer L, Kim SH., Methods Enzymol. January 1, 1997; 283 113-28.

Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition., Borgne A, Meijer L., J Biol Chem. November 1, 1996; 271 (44): 27847-54.

Purification of a 15-kDa cdk4- and cdk5-binding protein., Azzi L, Meijer L, Ostvold AC, Lew J, Wang JH., J Biol Chem. May 6, 1994; 269 (18): 13279-88.

8-Dimethylamino-1-methyladenine, a novel potent antagonist of the 1-methyladenine receptor in starfish oocytes., Monsees T, Meijer L, Jastorff B., Eur J Biochem. April 1, 1993; 213 (1): 155-65.

Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2., Azzi L, Meijer L, Reed SI, Pidikiti R, Tung HY., Eur J Biochem. February 1, 1992; 203 (3): 353-60.

Allene oxide and aldehyde biosynthesis in starfish oocytes., Brash AR, Hughes MA, Hawkins DJ, Boeglin WE, Song WC, Meijer L., J Biol Chem. December 5, 1991; 266 (34): 22926-31.

Cyclin B targets p34cdc2 for tyrosine phosphorylation., Meijer L, Azzi L, Wang JY., EMBO J. June 1, 1991; 10 (6): 1545-54.

High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase., Meijer L, Ostvold AC, Walass SI, Lund T, Laland SG., Eur J Biochem. March 28, 1991; 196 (3): 557-67.

A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates., Rialet V, Meijer L., Anticancer Res. January 1, 1991; 11 (4): 1581-90.

Negative control of cdc2 kinase activation by cAMP in starfish oocytes., Meijer L, Arion D., Cold Spring Harb Symp Quant Biol. January 1, 1991; 56 591-8.

Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components., Pondaven P, Meijer L, Beach D., Genes Dev. January 1, 1990; 4 (1): 9-17.

M-phase-specific protein kinase from mitotic sea urchin eggs: cyclic activation depends on protein synthesis and phosphorylation but does not require DNA or RNA synthesis., Arion D, Meijer L., Exp Cell Res. August 1, 1989; 183 (2): 361-75.

Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase., Meijer L, Arion D, Golsteyn R, Pines J, Brizuela L, Hunt T, Beach D., EMBO J. August 1, 1989; 8 (8): 2275-82.

Starfish oocyte maturation: evidence for a cyclic AMP-dependent inhibitory pathway., Meijer L, Dostmann W, Genieser HG, Butt E, Jastorff B., Dev Biol. May 1, 1989; 133 (1): 58-66.

Activation of myelin basic protein kinases during echinoderm oocyte maturation and egg fertilization., Pelech SL, Tombes RM, Meijer L, Krebs EG., Dev Biol. November 1, 1988; 130 (1): 28-36.

cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF., Arion D, Meijer L, Brizuela L, Beach D., Cell. October 21, 1988; 55 (2): 371-8.

Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions., Meijer L, Pondaven P., Exp Cell Res. January 1, 1988; 174 (1): 116-29.

Characterization of maturation-activated histone H1 and ribosomal S6 kinases in sea star oocytes., Pelech SL, Meijer L, Krebs EG., Biochemistry. December 1, 1987; 26 (24): 7960-8.

Differential regulation of histone H1 and ribosomal S6 kinases during sea star oocyte maturation., Meijer L, Pelech SL, Krebs EG., Biochemistry. December 1, 1987; 26 (24): 7968-74.

Starfish oocyte maturation: 1-methyladenine triggers a drop of cAMP concentration related to the hormone-dependent period., Meijer L, Zarutskie P., Dev Biol. June 1, 1987; 121 (2): 306-15.

Stereospecific induction of starfish oocyte maturation by (8R)-hydroxyeicosatetraenoic acid., Meijer L, Brash AR, Bryant RW, Ng K, Maclouf J, Sprecher H., J Biol Chem. December 25, 1986; 261 (36): 17040-7.

Contrasting effects of fatty acids on oocyte maturation in several starfish species., Meijer L, Maclouf J, Bryant RW., Prostaglandins Leukot Med. August 1, 1986; 23 (2-3): 179-84.

Protein phosphorylation and oocyte maturation. I. Induction of starfish oocyte maturation by intracellular microinjection of a phosphatase inhibitor, alpha-naphthylphosphate., Pondaven P, Meijer L., Exp Cell Res. April 1, 1986; 163 (2): 477-88.

Protein phosphorylation and oocyte maturation. II. Inhibition of starfish oocyte maturation by intracellular microinjection of protein phosphatases 1 and 2A and alkaline phosphatase., Meijer L, Pondaven P, Tung HY, Cohen P, Wallace RW., Exp Cell Res. April 1, 1986; 163 (2): 489-99.

Arachidonic acid, 12- and 15-hydroxyeicosatetraenoic acids, eicosapentaenoic acid, and phospholipase A2 induce starfish oocyte maturation., Meijer L, Guerrier P, Maclouf J., Dev Biol. December 1, 1984; 106 (2): 368-78.

Maturation and fertilization in starfish oocytes., Meijer L, Guerrier P., Int Rev Cytol. January 1, 1984; 86 129-96.

Calmodulin in starfish oocytes. II. Trypsin treatment suppresses the trifluoperazine-sensitive step., Meijer L, Guerrier P., Dev Biol. January 1, 1984; 101 (1): 257-62.

Immobilized methylglyoxal-bis(guanylhydrazone) induces starfish oocyte maturation., Meijer L, Guerrier P., Dev Biol. December 1, 1983; 100 (2): 308-17.

Trifluoperazine-Sensitive Step during Sea Urchin, Echiuroid and Pelecypod Egg Activation: (trifluoperazine/calmodulin/calcium/maturation/fertilization)., Meijer L, Dube F, Guerrier P., Dev Growth Differ. January 1, 1983; 25 (5): 469-475.

Activation of calmodulin-dependent NAD+ kinase by trypsin., Meijer L, Guerrier P., Biochim Biophys Acta. March 18, 1982; 702 (1): 143-6.

The role of calcium in meiosis reinitiation., Guerrier P, Moreau M, Meijer L, Mazzei G, Vilain JP, Dubé F., Prog Clin Biol Res. January 1, 1982; 91 139-55.

???pagination.result.page??? 1 2 ???pagination.result.next???